Terlipressin effect on hepatorenal syndrome: Updated meta-analysis of randomized controlled trials.
Mohamed Maali Gumaa MohamedAbdul RaufAbubakr AdamBabikir KheiriAlexandre LacasseHani El-HalawanyPublished in: JGH open : an open access journal of gastroenterology and hepatology (2021)
In patients with liver cirrhosis complicated by HRS, terlipressin was associated with significant HRS reversal and decrease in serum Cr. No survival benefit was detected at 90 days.